The Latest Cardiac and Vascular News
Non-tapered metal-alloy support catheter platform receives FDA clearance for use in coronary and peripheral vasculature. Transit Scientific now has one of the largest platforms of FDA cleared microcatheters in the industry. PARK CITY, Utah, April 12, 2022 /PRNewswire/ — Transit Scientific announced the FDA clearance of its XO Cross® Support Catheter Platform to […]
Multicenter ACTIVATE II Study to Enroll up to 50 Patients in Australia SALT LAKE CITY–(BUSINESS WIRE)–Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based First-in-Human clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding (AlucentNVS) technology. The therapy is […]
First regulatory milestone as part of a strategy to advance patient care CAMPBELL, Calif.–(BUSINESS WIRE)–Truvic Medical, Inc., a wholly owned subsidiary of Imperative Care, Inc., today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Prodigy™ Thrombectomy System, designed for the treatment of peripheral […]
With this move, government hospitals across India can now access the geko™ device to prevent life threatening blood clots, address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers). DARESBURY, England, April 6, 2022 /PRNewswire/ — Sky Medical Technology Ltd (Sky), a UK-based medical device manufacturer and parent company […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows. U.S. patent […]
An analysis showed benefit of XARELTO® plus aspirin in reducing thrombotic hospitalizations for PAD patients with and without chronic kidney disease (CKD) A separate analysis demonstrated PAD patients who received XARELTO® plus aspirin in addition to statin therapy had the lowest risk of the composite of major adverse cardiovascular events (MACE) or major adverse […]
Bloomington, Ind. — Cook Medical’s Zenith® Thoraco+ Endovascular System (Thoraco+) has received Breakthrough Device Designation from the US Food and Drug Administration (FDA). This designation is granted to devices that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions. While the product is […]
Through Save Legs. Change Lives.™, Janssen seeks to elevate PAD research, collaboration, education and screening for communities placed at increased risk of cardiovascular disease TITUSVILLE, N.J., March 31, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch of Save Legs. Change Lives.™ Spot Peripheral Artery Disease Now, a multi-year […]
Shockwave M5+ IVL Catheter Broadens Options for Treatment of Peripheral Arteries SANTA CLARA, Calif., March 31, 2022 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the global commercial availability of the Shockwave M5+ peripheral […]
BRIDGEWATER, N.J., March 30, 2022 /PRNewswire/ — Nipro Medical Corporation (Nipro), a leading manufacturer and supplier of renal, vascular, and medical-surgical products, welcomes a second-gen Cronus® HP PTA Balloon Catheter to the U.S. Cronus® HP is a high pressure (HP) percutaneous transluminal angioplasty (PTA) balloon catheter indicated for use in popliteal, femoral, iliac, and renal […]
